CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
An Investigational Drug, Palbociclib (PD-0332991), Is Being Studied In Combination With Velcade And Dexamethasone In Patients With Multiple Myeloma. Patients Must Have Received Prior Treatment For Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Phase II Study of Dexamethasone, Thalidomide and Lenalidomide for Subjects With Relapsed or Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Phase II Study of Thalidomide, Clarithromycin, Lenalidomide, and Dexamethasone for Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Dexamethasone to Treat Acute Chest Syndrome in People With Sickle Cell Disease
- Status
- TERMINATED
- Phase
- PHASE3
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
- Status
- COMPLETED
- Phase
- PHASE4
Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy
- Status
- TERMINATED
- Phase
- PHASE2
Bortezomib and Dexamethasone With or Without Lenalidomide in Treating Patients With Multiple Myeloma Previously Treated With Dexamethasone
- Status
- TERMINATED
- Phase
- PHASE3
Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Intravenous Dexamethasone for Acute Disc Herniation-Induced Sciatica
- Status
- UNKNOWN
- Phase
- NA
Papillary Serous Carcinoma of the Endometrium
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2